- Home
- MNKD vs BST Comparison
MNKD vs BST Comparison
Compare MNKD & BST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MNKD | BST |
|---|---|---|
| Founded | 1991 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.4B |
| IPO Year | 2004 | N/A |
Fundamental Metrics
Financial Performance| Metric | MNKD | BST |
|---|---|---|
| Price | $6.00 | $40.06 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $10.08 | N/A |
| AVG Volume (30 Days) | ★ 2.8M | 108.7K |
| Earning Date | 11-05-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.32% |
| EPS Growth | ★ 23.47 | N/A |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $313,787,000.00 | N/A |
| Revenue This Year | $21.54 | N/A |
| Revenue Next Year | $22.21 | N/A |
| P/E Ratio | $60.68 | ★ N/A |
| Revenue Growth | ★ 17.43 | N/A |
| 52 Week Low | $3.38 | $27.87 |
| 52 Week High | $7.07 | $44.50 |
Technical Indicators
Market Signals| Indicator | MNKD | BST |
|---|---|---|
| Relative Strength Index (RSI) | 66.29 | 42.99 |
| Support Level | $5.59 | $40.74 |
| Resistance Level | $5.90 | $41.50 |
| Average True Range (ATR) | 0.19 | 0.58 |
| MACD | 0.06 | 0.11 |
| Stochastic Oscillator | 99.47 | 56.08 |
Price Performance
Historical ComparisonAbout MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
About BST BlackRock Science and Technology Trust of Beneficial Interest
BlackRock Science and Technology Trust is a closed-end management investment company. Its investment objective is to provide income and total return through a combination of current income, current gains, and long-term capital appreciation. It focuses on investing, under a normal market condition in equity securities of science and technology companies.